XML 31 R12.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Intangible Assets and Goodwill
3 Months Ended
Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible Assets and Goodwill Intangible assets and goodwill
Intangible assets that have finite useful lives are amortized over their estimated useful lives. The latest annual impairment assessment of goodwill and indefinite lived intangible assets was completed in the fiscal fourth quarter of 2023. Future impairment tests for goodwill and indefinite lived intangible assets will be performed annually in the fiscal fourth quarter, or sooner, if warranted.
(Dollars in Millions)March 31, 2024December 31, 2023
Intangible assets with definite lives:  
Patents and trademarks — gross$39,19840,417
Less accumulated amortization(24,826)(24,808)
Patents and trademarks — net14,37215,609
Customer relationships and other intangibles — gross19,93020,322
Less accumulated amortization(12,742)(12,685)
Customer relationships and other intangibles — net(1)
7,1887,637
Intangible assets with indefinite lives:  
Trademarks1,6491,714
Purchased in-process research and development11,0779,215
Total intangible assets with indefinite lives12,72610,929
Total intangible assets — net$34,28634,175
(1)The majority is comprised of customer relationships
Goodwill as of March 31, 2024 was allocated by segment of business as follows:
(Dollars in Millions)
Innovative
Medicine
MedTechTotal
Goodwill at December 31, 2023
$10,40726,15136,558
Goodwill, related to acquisitions290290
Goodwill, related to divestitures
Currency translation/Other(145)(87)(232)
Goodwill at March 31, 2024
$10,55226,06436,616
    
The weighted average amortization period for patents and trademarks is approximately 11 years. The weighted average amortization period for customer relationships and other intangible assets is approximately 18 years. The amortization expense of amortizable intangible assets included in the cost of products sold was $1.1 billion and $1.1 billion for the fiscal first quarters ended March 31, 2024 and April 2, 2023, respectively. Intangible asset write-downs are included in Other (income) expense, net.
The estimated amortization expense for approved products, before tax, for the five succeeding years is approximately:
(Dollars in Millions)
20242025202620272028
$4,3003,5002,9002,3001,600
See Note 10 to the Consolidated Financial Statements for additional details related to acquisitions and divestitures.